Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.
N/A
Dose of anticoagulant prophylaxis in patients with continuous veno-venous h...
Status
Unknown
Location
Medical University of Gdansk - Departament of Anesthesiology and Intensive Care
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
N/A
Venous Thromboembolism (VTE), including deep vein thrombosis (DVT) and pulm...
Status
Terminated
Location
Sanofi U.S.
Start Date
2023-04-25
Trial ID
NCT05819112
Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots
N/A
Background: Venous thromboembolism (VTE), which includes deep vein thrombos...
Status
Terminated
Location
Queen Elizabeth II Medical Centre
Start Date
2016-05
Trial ID
NCT02752607
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
PHASE4
Worldwide observational studies indicate a significant prothrombogenic effe...